A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.

A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy.

Complete clinical regressions of solid tumors in response to chemotherapy are difficult to explain by direct cytotoxicity alone, because of low growth fractions and obstacles to drug delivery. A plausible indirect mechanism that might reconcile this is the action of the immune system. A model for in...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Robertson-Tessi, M, El-Kareh, A, Goriely, A
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Elsevier 2015

समान संसाधन

A mathematical model of tumor-immune interactions.
द्वारा: Robertson-Tessi, M, और अन्य
प्रकाशित: (2012)

A mathematical model of tumor-immune interactions
द्वारा: Robertson-Tessi, M, और अन्य
प्रकाशित: (2010)

An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
द्वारा: Xinyuan Yuan, और अन्य
प्रकाशित: (2023-12-01)

The Goldilocks window of personalized chemotherapy: Getting the immune response just right
द्वारा: Park, D, और अन्य
प्रकाशित: (2019)

Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
द्वारा: Xiaoxian Huang, और अन्य
प्रकाशित: (2022-12-01)

Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
द्वारा: Marion Thibaudin, और अन्य
प्रकाशित: (2023-12-01)

A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma via remodeling tumor immune microenvironment
द्वारा: Leilei Wang, और अन्य
प्रकाशित: (2024-05-01)

Tumor immune dysfunction and exclusion evaluation and chemoimmunotherapy response prediction in lung adenocarcinoma using pathomic-based approach
द्वारा: Wei Nie, और अन्य
प्रकाशित: (2025-02-01)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
द्वारा: Margaret R. Smith, और अन्य
प्रकाशित: (2023-03-01)

Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
द्वारा: Jun Gu, और अन्य
प्रकाशित: (2022-08-01)

Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification
द्वारा: Manxiu Huai, और अन्य
प्रकाशित: (2024-05-01)

Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug
द्वारा: Jinxiao Song, और अन्य
प्रकाशित: (2023-03-01)

Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma.
द्वारा: Katherine Dittrich, और अन्य
प्रकाशित: (2023-01-01)

Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
द्वारा: Zhichao Liu, और अन्य
प्रकाशित: (2022-07-01)

In situ chemoimmunotherapy hydrogel elicits immunogenic cell death and evokes efficient antitumor immune response
द्वारा: Qin Liu, और अन्य
प्रकाशित: (2024-04-01)

Comparison of Immunotherapy, Chemotherapy, and Chemoimmunotherapy in Advanced Pulmonary Lymphoepithelioma-Like Carcinoma： A Retrospective Study
द्वारा: Yi Xiao, और अन्य
प्रकाशित: (2022-02-01)

Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma
द्वारा: Xin Wang, और अन्य
प्रकाशित: (2020-10-01)

Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma
द्वारा: Dongyang Yang, और अन्य
प्रकाशित: (2022-10-01)

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition
द्वारा: Strobl, MAR, और अन्य
प्रकाशित: (2022)

Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
द्वारा: Udo S Gaipl, और अन्य
प्रकाशित: (2022-01-01)

Ferritin‐Based Nanocomposite Hydrogel Promotes Tumor Penetration and Enhances Cancer Chemoimmunotherapy
द्वारा: Rong Liu, और अन्य
प्रकाशित: (2024-01-01)

Activation of autophagy by in situ Zn2+ chelation reaction for enhanced tumor chemoimmunotherapy
द्वारा: Yang Yang, और अन्य
प्रकाशित: (2023-11-01)

Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells
द्वारा: Koh Nakata, और अन्य
प्रकाशित: (2011-01-01)

Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
द्वारा: Seung Mo Jin, और अन्य
प्रकाशित: (2021-10-01)

Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
द्वारा: Charlotte R. Bell, और अन्य
प्रकाशित: (2022-04-01)

182 Peripheral immunological features as predictors of breast cancer chemoimmunotherapy response
द्वारा: Justin M Balko, और अन्य
प्रकाशित: (2023-11-01)

Letter: Chemoimmunotherapy of adult acute leukaemia.
द्वारा: Peto, R, और अन्य
प्रकाशित: (1975)

Application of Neoadjuvant Chemoimmunotherapy in Resectable NSCLC
द्वारा: Huaiyong WANG, और अन्य
प्रकाशित: (2023-11-01)

MAPK signaling regulates the efficacy of chemoimmunotherapy
द्वारा: François Ghiringhelli
प्रकाशित: (2022-12-01)

Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation
द्वारा: West, J, और अन्य
प्रकाशित: (2024)

Safety and Efficacy of Neoadjuvant Chemoimmunotherapy versus Chemotherapy for Non-Small Cell Lung Cancer Undergoing Sleeve Resection
द्वारा: Qiu Y, और अन्य
प्रकाशित: (2024-09-01)

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib
द्वारा: Baustin M. Welch, और अन्य
प्रकाशित: (2023-12-01)

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition
द्वारा: Maximilian A. R. Strobl, और अन्य
प्रकाशित: (2022-04-01)

Tumor-immune metaphenotypes orchestrate an evolutionary bottleneck that promotes metabolic transformation
द्वारा: Jeffrey West, और अन्य
प्रकाशित: (2024-02-01)

Adaptive fuzzy controller design of drug dosage using optimal trajectories in a chemoimmunotherapy cancer treatment model
द्वारा: Hossein Naderi, और अन्य
प्रकाशित: (2021-01-01)

Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment
द्वारा: Lang X, और अन्य
प्रकाशित: (2024-05-01)

THE CHEMOIMMUNOTHERAPY BASED ON DENDRITIC CELLS AND CISPLATIN IN EXPERIMENT
द्वारा: Gorbach O. I., और अन्य
प्रकाशित: (2014-08-01)

Efficacy and safety of neoadjuvant chemoimmunotherapy and chemotherapy in patients with potentially resectable stage IIIA/IIIB NSCLC: a retrospective study
द्वारा: Yuchen Wang, और अन्य
प्रकाशित: (2025-01-01)

Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study
द्वारा: Tianxiang Chen, MD, PhD, और अन्य
प्रकाशित: (2023-04-01)

A real‐world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non‐small cell lung cancer
द्वारा: Baihua Zhang, और अन्य
प्रकाशित: (2023-01-01)